Voyager Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Voyager Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Voyager Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $35.5M, a 144% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $35.5M +$21M +144% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $39.2M +$24.2M +161% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $13.5M -$1.98M -12.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $14M -$1.92M -12% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $14.5M -$1.86M -11.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $15M -$17.4M -53.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $15.5M -$18M -53.7% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $15.9M -$17.9M -52.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $16.4M -$17.8M -52% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $32.4M -$2.74M -7.79% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $33.5M -$2.61M -7.23% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $33.8M +$7.67M +29.3% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $34.1M +$7.15M +26.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $35.1M +$7.38M +26.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $36.1M +$7.59M +26.7% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $26.1M -$3.2M -10.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $27M -$3.05M -10.2% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $27.7M -$2.56M -8.44% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $28.5M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $29.3M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $30M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $30.3M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.